FDA Inspection 1224796 — American Reproductive Centers

American Reproductive Centers — FEI 3008608338

The FDA completed an inspection of American Reproductive Centers on December 6, 2023 in Palm Springs, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 6, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Palm Springs, CA (United States)

Citations

IDCFRDescription
1223021 CFR 1271.50(a)Responsible person to determine, document
1228621 CFR 1271.80(b)Specimen collections not timely